Prefer Newsweek on Google to see more of our trusted coverage when you search. Mississippi has been crowned the unhealthiest state in the U.S., according to data collected on national rates of obesity ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...

Obesity ups the risk for a number of skin conditions and infections, including stretch marks, cellulitis, and cutaneous candidiasis.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Diabetes is a chronic condition that impacts a large ...

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

India is facing a silent surge in fatty liver disease (MASLD), rising sharply since 1990 due to increasing diabetes and ...

Driven by obesity and diabetes, the condition is rising rapidly worldwide, often silently increasing risks of cirrhosis and liver cancer.

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. The body mass index is not going away, a new ...

On March 22, 2026, the originator company, Novo Nordisk’s patent for semaglutide (the active ingredient) expired, and the ...

A study of over 620,000 people found that weight gain in your 20s carries disproportionately high and lasting risks of ...

Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity, under a directive issued last week by the Trump administration.